ARIS vs. NBIX
ARIS (Aris Water Solutions, Inc.) and NBIX (Neurocrine Biosciences, Inc.) are both stocks. ARIS operates in Utilities - Regulated Water (Utilities), while NBIX operates in Drug Manufacturers - Specialty & Generic (Healthcare). Over the past 3 years, ARIS returned 82.13%/yr vs 21.73%/yr for NBIX. At a 0.06 correlation, their price movements are largely independent.
Performance
ARIS vs. NBIX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ARIS achieves a -10.29% return, which is significantly lower than NBIX's 24.87% return.
ARIS
- 1D
- -1.29%
- 1M
- -3.58%
- 6M
- -12.61%
- YTD
- -10.29%
- 1Y
- 106.52%
- 3Y*
- 82.13%
- 5Y*
- —
- 10Y*
- —
NBIX
- 1D
- -1.91%
- 1M
- 8.85%
- 6M
- 30.43%
- YTD
- 24.87%
- 1Y
- 32.71%
- 3Y*
- 21.73%
- 5Y*
- 12.33%
- 10Y*
- 13.85%
ARIS vs. NBIX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
ARIS Aris Water Solutions, Inc. | -10.29% | 363.71% | 6.54% | 31.93% | -39.60% | 1.33% |
NBIX Neurocrine Biosciences, Inc. | 24.87% | 3.90% | 3.60% | 10.31% | 40.24% | -18.11% |
Correlation
The correlation between ARIS and NBIX is 0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.02 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.04 |
Correlation (All Time) Calculated using the full available price history since Oct 22, 2021 | 0.06 |
Fundamentals
ARIS:
$3.01B
NBIX:
$17.81B
ARIS:
$0.85
NBIX:
$6.50
ARIS:
17.19
NBIX:
27.23
ARIS:
0.34
NBIX:
0.54
ARIS:
2.61
NBIX:
5.87
ARIS:
1.94
NBIX:
5.37
ARIS:
$1.14B
NBIX:
$3.10B
ARIS:
$612.94M
NBIX:
$3.05B
ARIS:
$432.53M
NBIX:
$881.20M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ARIS vs. NBIX — Risk / Return Rank
ARIS
NBIX
ARIS vs. NBIX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Aris Water Solutions, Inc. (ARIS) and Neurocrine Biosciences, Inc. (NBIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ARIS | NBIX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.15 | ||
| Sortino ratioReturn per unit of downside risk | +0.90 | ||
| Omega ratioGain probability vs. loss probability | 1.33 | 1.20 | +0.13 |
| Calmar ratioReturn relative to maximum drawdown | 3.71 | 1.50 | +2.21 |
| Martin ratioReturn relative to average drawdown | 10.23 | 3.29 | +6.94 |
Loading charts...
Drawdowns
ARIS vs. NBIX - Drawdown Comparison
The maximum ARIS drawdown since its inception was -57.98%, smaller than the maximum NBIX drawdown of -97.21%. Use the drawdown chart below to compare losses from any high point for ARIS and NBIX.
Loading charts...
Drawdown Indicators
| ARIS | NBIX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -57.98% | -97.21% | +39.23% |
Max Drawdown (1Y)Largest decline over 1 year | -35.29% | -20.90% | -14.39% |
Max Drawdown (3Y)Largest decline over 3 years | -35.29% | -42.89% | +7.60% |
Max Drawdown (5Y)Largest decline over 5 years | — | -42.89% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -46.39% | — |
Current DrawdownCurrent decline from peak | -32.75% | -1.91% | -30.84% |
Average DrawdownAverage peak-to-trough decline | -22.75% | -43.74% | +20.99% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.01% | 9.52% | +2.49% |
Volatility
ARIS vs. NBIX - Volatility Comparison
Aris Water Solutions, Inc. (ARIS) has a higher volatility of 21.89% compared to Neurocrine Biosciences, Inc. (NBIX) at 8.08%. This indicates that ARIS's price experiences larger fluctuations and is considered to be riskier than NBIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ARIS | NBIX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 21.89% | 8.08% | +13.81% |
Volatility (6M)Calculated over the trailing 6-month period | 47.67% | 23.42% | +24.25% |
Volatility (1Y)Calculated over the trailing 1-year period | 61.12% | 31.73% | +29.39% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 53.45% | 32.83% | +20.62% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 53.45% | 39.03% | +14.42% |
Dividends
ARIS vs. NBIX - Dividend Comparison
Neither ARIS nor NBIX has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
ARIS Aris Water Solutions, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 3.84% | 0.85% |
NBIX Neurocrine Biosciences, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
ARIS vs. NBIX - Financials Comparison
This section allows you to compare key financial metrics between Aris Water Solutions, Inc. and Neurocrine Biosciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ARIS vs. NBIX - Profitability Comparison
ARIS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Aris Water Solutions, Inc. reported a gross profit of 217.03M and revenue of 372.48M. Therefore, the gross margin over that period was 58.3%.
NBIX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Neurocrine Biosciences, Inc. reported a gross profit of 800.70M and revenue of 814.50M. Therefore, the gross margin over that period was 98.3%.
ARIS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Aris Water Solutions, Inc. reported an operating income of 179.05M and revenue of 372.48M, resulting in an operating margin of 48.1%.
NBIX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Neurocrine Biosciences, Inc. reported an operating income of 193.40M and revenue of 814.50M, resulting in an operating margin of 23.7%.
ARIS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Aris Water Solutions, Inc. reported a net income of 97.61M and revenue of 372.48M, resulting in a net margin of 26.2%.
NBIX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Neurocrine Biosciences, Inc. reported a net income of 197.90M and revenue of 814.50M, resulting in a net margin of 24.3%.
Frequently Asked Questions
ARIS and NBIX have a correlation of 0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ARIS has higher volatility (21.89%) compared to NBIX (8.08%). In terms of maximum drawdown, ARIS dropped -57.98% vs NBIX's -97.21%.
ARIS currently has the higher Sharpe Ratio (2.14 vs 0.99), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ARIS and NBIX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer